Sign Out
For continuous combined HRT regimen: Femoston Conti 1/5: Hormone Replacement Therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women with a uterus, at least 12 months since last menses.
Prevention of osteoporosis in postmenopausal women with a uterus, at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.
For continuous sequential HRT regimen: Femoston 1/10: Hormone Replacement Therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses.
Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.
For continuous sequential HRT regimen: Femoston 2/10: Hormone Replacement Therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses.
All Formulations: Elderly population: The experience in treating women older than 65 years is limited.
Continue with Google